Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

stage IV uterine sarcoma

Known as: uterine sarcoma, metastatic, uterine sarcoma, stage IV, metastatic uterine sarcoma 
Stage IV includes: IVA (T4, Any N, M0); IVB (Any T, Any N, M1). T4: Tumor involves bladder or rectum. M0: No distant metastasis. M1: Distal… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
  • A. Chiesa-Vottero
  • International journal of gynecological pathology…
  • 2019
  • Corpus ID: 205942203
Seven cases of actinomycotic endometritis were identified among 28,906 endometrial biopsies performed in the last 10 yr. The… Expand
2019
2019
PURPOSE Uterine sarcoma accounts for 3-9% of uterine malignant tumors and has poor prognosis. Pazopanib is an oral multi-kinase… Expand
  • table 1
  • figure 1
  • figure 2
2018
2018
Objective In the treatment of metastatic soft tissue sarcoma (STS), pazopanib is considered a standard treatment after failure of… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2015
2015
Uterine sarcomas are rare and aggressive gynecologic tumors with a poor prognosis because of recurrence and metastasis. However… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Review
2013
Review
2013
AIM To gain more information about the knowledge of the clinical management of uterine sarcoma. MATERIALS AND METHODS This… Expand
Review
2013
Review
2013
Background: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40… Expand
  • figure 1
  • figure 2
  • figure 4
Review
2006
Review
2006
15053 Background: The prognosis of metastatic uterine sarcoma is poor with median survival reported between 4 to 26 months. We… Expand
  • table 1
  • table 2
  • table 3
Review
2004
Review
2004
5105 Background: Uterine sarcomas are rare and management of metastatic disease often conforms to treatment practice for other… Expand
Review
2004
Review
2004
5143 Background: The prognosis of metastatic uterine sarcoma is poor with median survival reported between 4-26 months. The… Expand
1956
1956
Abstract A report is cited of a patient with sarcoma presumedly metastatic to the lung. Treatment consisted of total… Expand